PRESCRIBER PROFILE AND POSTMARKETING SURVEILLANCE

被引：2
|
作者：
INMAN, WHW
PEARCE, G
机构：
[1] Drug Safety Research Unit, Southampton, S03 8BA, Bursledon Hall
来源：
LANCET | 1993年 / 342卷 / 8885期
关键词：
D O I：
10.1016/0140-6736(93)92973-W
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1491 / 1491
页数：1
相关论文
共 50 条
  • [31] A Call for Improved Postmarketing Surveillance
    Zito, Julie Magno
    HASTINGS CENTER REPORT, 2011, 41 (02) : S24 - S24
  • [32] RETROVIR - THE CHALLENGE OF POSTMARKETING SURVEILLANCE
    JOSEPH, MC
    CREAGHKIRK, T
    PHARMACOEPIDEMIOLOGY, VOL 1, 1989, : 289 - 302
  • [33] RCT OF POSTMARKETING SURVEILLANCE METHODS
    LEVINE, MAH
    HAMET, P
    NOVOSEL, S
    JOLAIN, B
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 147 - 147
  • [34] POSTMARKETING SURVEILLANCE AND THE ROLE OF THE PHARMACIST
    DEKONING, GHP
    PROGRESS IN CLINICAL PHARMACY: RATIONAL USE OF DRUGS, 1989, : 163 - 168
  • [35] Postmarketing surveillance for drug abuse
    Arfken, CL
    Cicero, TJ
    DRUG AND ALCOHOL DEPENDENCE, 2003, 70 (03) : S97 - S105
  • [36] Postmarketing Surveillance of Medical Devices
    Villegas, Dorian
    Ye, Wendy
    Ayela-Wangue, Osas
    Schneiweiss, Fred
    Babuschak, Jeff
    Yonren, Samuel
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S234 - S234
  • [37] POSTMARKETING SURVEILLANCE OF NEW DRUGS
    BUCKLEY, EG
    JOURNAL OF THE ROYAL COLLEGE OF GENERAL PRACTITIONERS, 1987, 37 (301): : 337 - 338
  • [38] POSTMARKETING SURVEILLANCE OF VACCINES IN THE USA
    不详
    LANCET, 1990, 336 (8724): : 1183 - 1183
  • [39] POSTMARKETING SURVEILLANCE IN THE UK (1984)
    LAWSON, DH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 : S71 - S75
  • [40] Postmarketing surveillance - Demise or rebirth?
    Waller, PC
    Wood, SM
    Langman, MJS
    Breckenridge, AM
    Rawlins, MD
    ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS, 1996, 15 (01): : 71 - 72
12345